AFM13 (CD30 × CD16A) is a tetravalent BsAb that targets CD16A and CD30, expressed in Hodgkin and Reed-Sternberg cells of patients with Hodgkin’s lymphoma [25]. Here, TNFRSF8 is linked to Hodgkins lymphoma.